Zimmer Biomet, Stryker and Smith+Nephew all recently reported their third quarter results. While Smith+Nephew and Zimmer Biomet saw dips in orthopedic performance, Stryker saw revenue gains.
Here's a comparison of their performances:
Zimmer Biomet
Total sales: $1.9 billion
U.S. hip sales: $244.2 million
U.S. knee sales: $386.3 million
Spine and dental sales: $238.6 million
Stryker
Total sales: $4.2 billion
Hip sales: $328 million
Knee sales $439 million
Neurotechnology and spine sales: $876 million
Smith+Nephew
Total sales: $1.3 billion
Hip sales: $145 million
Knee sales: $207 million
Orthopedic sales: $508 million